Correlation Between Bristol Myers and Avid Bioservices

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Avid Bioservices at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Avid Bioservices into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Avid Bioservices, you can compare the effects of market volatilities on Bristol Myers and Avid Bioservices and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Avid Bioservices. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Avid Bioservices.

Diversification Opportunities for Bristol Myers and Avid Bioservices

-0.58

Correlation Coefficient

Bristol Myers  Avid Bioservices

Excellent diversification

The 3 months correlation between Bristol and Avid is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Avid Bioservices in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avid Bioservices and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Avid Bioservices. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avid Bioservices has no effect on the direction of Bristol Myers i.e., Bristol Myers and Avid Bioservices go up and down completely randomly.

Pair Corralation between Bristol Myers and Avid Bioservices

Considering the 90-day investment horizon Bristol Myers Squibb is expected to under-perform the Avid Bioservices. But the stock apears to be less risky and, when comparing its historical volatility, Bristol Myers Squibb is 3.49 times less risky than Avid Bioservices. The stock trades about -0.1 of its potential returns per unit of risk. The Avid Bioservices is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  744.00  in Avid Bioservices on February 19, 2024 and sell it today you would earn a total of  176.00  from holding Avid Bioservices or generate 23.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Bristol Myers Squibb  vs.  Avid Bioservices

Bristol Myers Squibb

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Avid Bioservices

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Avid Bioservices are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady primary indicators, Avid Bioservices displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bristol Myers and Avid Bioservices

The main advantage of trading using opposite Bristol Myers and Avid Bioservices positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Avid Bioservices can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avid Bioservices will offset losses from the drop in Avid Bioservices' long position.

The idea behind Bristol Myers Squibb and Avid Bioservices pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.